AKTS

Aktis Oncology, Inc.

Healthcare · USD

Set alert

Price alert · AKTS

All alert types
15.93 USD -0.92 -5.46%
As of Oct 30, 2026 Extended hours 15.93 0.00%
Bid
15.92 × 2
Ask
15.96 × 2
15.77 Day range 17.03
14.72 52-week range 34.19
YTD
-28.88%
1 year
-28.88%
Open
17.03
Prev close
16.85
Mkt cap
886.02M
Vol
251.54K
Avg vol
361.91K
EPS
-1.70
P/E
0.00
Div yield
0.00%
More statistics
Low
15.77
High
17.03
Forward P/E
-8.45
Beta
0.00
Short ratio
10.89
Inst. own
73.01%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
22.96
200-d avg
21.42
1y target
35.39

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for AKTS has not been loaded yet. Try again in a moment.

Period ending Jun 30, 2026 · select a line to chart its history

Revenue & Expenses

Other Income → Expenses: $4.75MExpenses → Selling, General & Admin: $6.12MExpenses → Research & Development: $25.28MGross Profit → Expenses: $2.50MRevenue → Gross Profit: $2.50MRevenue → Cost of Revenue: $879.00KNet Loss → Expenses: $24.14MOther Income$4.75MGross Profit$2.50MNet Loss$24.14MCost of Revenue$879.00KExpenses$31.40MSelling, General & Admin$6.12MResearch & Development$25.28MRevenue$3.38M

Income statement

AKTS quarterly income statement
3.38M
3.38M
3.38M
32.28M
25.28M
7.00M
-28.90M
-24.14M
-24.14M
-24.14M
-24.14M
-0.44
-0.44
-0.44
-24.14M
-24.14M
55.30M
55.30M

Balance sheet

AKTS quarterly balance sheet
83.64M
83.64M
434.83M
434.83M
524.54M
28.20M
557.60M
1.48M
11.24M
32.13M
9.76M
72.76M
-199.03M
-745.00K
484.84M
484.84M
33.06M
11.24M
48.21M
40.63M
2.53M

Cash flow

AKTS quarterly cash flow
879.00K
156.00K
-289.14M
-1.26M
156.00K
-268.71M
-267.45M
-20.59M
3.22M